0001815849-24-000044.txt : 20240612 0001815849-24-000044.hdr.sgml : 20240612 20240612161335 ACCESSION NUMBER: 0001815849-24-000044 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240612 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Submission of Matters to a Vote of Security Holders ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240612 DATE AS OF CHANGE: 20240612 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ATI Physical Therapy, Inc. CENTRAL INDEX KEY: 0001815849 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-NURSING & PERSONAL CARE FACILITIES [8050] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 851408039 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39439 FILM NUMBER: 241038548 BUSINESS ADDRESS: STREET 1: 790 REMINGTON BOULEVARD CITY: BOILINGBROOK STATE: IL ZIP: 60440 BUSINESS PHONE: 630-296-2223 MAIL ADDRESS: STREET 1: 790 REMINGTON BOULEVARD CITY: BOILINGBROOK STATE: IL ZIP: 60440 FORMER COMPANY: FORMER CONFORMED NAME: Fortress Value Acquisition Corp. II DATE OF NAME CHANGE: 20200622 8-K 1 ati-20240612.htm 8-K ati-20240612
false000181584900018158492024-06-122024-06-120001815849us-gaap:CommonClassAMember2024-06-122024-06-120001815849us-gaap:WarrantMember2024-06-122024-06-12

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________________
FORM 8-K
___________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): June 12, 2024
___________________________________
ATI Physical Therapy, Inc.
(Exact name of registrant as specified in its charter)
___________________________________
Delaware
(State or other jurisdiction of
incorporation or organization)
001-39439
(Commission File Number)
85-1408039
(I.R.S. Employer Identification Number)
790 Remington Boulevard
Bolingbrook, IL 60440
(Address of principal executive offices and zip code)
(630) 296-2223
(Registrant's telephone number, including area code)
___________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Class A common stock, par value $0.0001ATIPNew York Stock Exchange
Redeemable Warrants, exercisable for Class A common stock at an exercise price of $575.00 per shareATIPWOTC Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 12b-2 of the Exchange Act.
Emerging growth company    
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.




ITEM 5.02     DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.

At the 2024 Annual Meeting of Stockholders of ATI Physical Therapy, Inc. (the “Company”), which was held on June 12, 2024 (the “2024 Annual Meeting”), the Company’s stockholders approved a third amendment (the “Plan Amendment”) to the Company’s 2021 Equity Incentive Plan (the “Plan”) to increase the aggregate number of shares of Class A common stock, par value $0.0001 per share (the “Common Stock”), authorized for issuance under the Plan by an additional 4,500,000 shares of Common Stock, as described in the Company’s proxy statement for the 2024 Annual Meeting filed with the Securities and Exchange Commission on April 26, 2024 (the “Proxy Statement”). The Plan Amendment had previously been approved, subject to stockholder approval, by the Company’s board of directors.

The Company’s executive officers and directors are eligible to receive awards under the Plan, including stock options and restricted stock units, in accordance with the terms and conditions of the Plan. A detailed summary of the Plan and the Plan Amendment is set forth in the Proxy Statement under the caption “Proposal 4: Approval of the Amendment to the ATI Physical Therapy, Inc. 2021 Equity Incentive Plan to Increase the Number of Shares Available for Issuance under the Plan,” the summary of which is incorporated herein by reference. That detailed summary of the Plan and the foregoing description of the Plan Amendment are qualified in their entirety by reference to the full text of the Plan and Plan Amendment, which are filed as Exhibit 10.1 and 10.4, respectively, to this Current Report on Form 8-K and incorporated herein by reference.

ITEM 5.07     SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

The 2024 Annual Meeting of the Company was held on June 12, 2024. As of April 15, 2024, the record date for the 2024 Annual Meeting, 4,395,593 shares of Common Stock were outstanding and entitled to vote and holders of our Series B Preferred Stock were entitled to the number of votes as determined as if their shares of Series B Preferred Stock were converted into Common Stock, or 10,514,376 votes, voting together with the holders of the Common Stock as a single class on all matters. At the 2024 Annual Meeting, stockholders voted on the following proposals:

PROPOSAL I: To ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. The votes were as follows:

FOR13,902,420 
AGAINST13,378 
ABSTAIN7,113 

PROPOSAL II: Election of Directors.

Joanne Burns, James Parisi, Sharon Vitti, Daniel Dourney, Jeff Goldberg, John Larsen, Carmine Petrone, Randy Raisman and Andrew Shannahan were each re-elected as Directors, to serve a one year term to expire at the 2025 annual meeting of stockholders or until their respective successors are elected and qualified or until their earlier resignation, removal from office or death. The votes were as follows:

For
Withheld
Broker Non-Votes
Joanne Burns13,202,528 136,128 584,255 
James Parisi13,319,035 19,621 584,255 
Sharon Vitti13,320,760 17,896 584,255 
Daniel Dourney13,322,999 15,657 584,255 
Jeff Goldberg13,323,103 15,553 584,255 
John Larsen13,208,935 129,721 584,255 
Carmine Petrone13,244,120 94,536 584,255 
Randy Raisman13,253,445 85,211 584,255 
Andrew Shannahan13,316,292 22,364 584,255 




PROPOSAL III: To approve, on a non-binding advisory basis, the compensation of our Named Executive Officers. The votes were as follows:

FOR13,293,712
AGAINST43,258
ABSTAIN1,686
BROKER NON-VOTES584,255

PROPOSAL IV: To approve an amendment to ATI Physical Therapy, Inc.’s 2021 Equity Incentive Plan to increase the number of shares available for issuance thereunder. The votes were as follows:

FOR13,180,902
AGAINST156,508
ABSTAIN1,246
BROKER NON-VOTES584,255

ITEM 9.01
FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits
Exhibit
No.
Description
2021 Equity Incentive Plan (filed as Exhibit 10.1 to the Current Report on Form 8-K of the Company on June 13, 2023 and incorporated herein by reference).
First Amendment to 2021 Equity Incentive Plan (filed as Exhibit 10.2 to the Current Report on Form 8-K of the Company on June 13, 2023 and incorporated herein by reference).
Second Amendment to 2021 Equity Incentive Plan (filed as Exhibit 10.3 to the Current Report on Form 8-K of the Company on June 13, 2023 and incorporated herein by reference).
Third Amendment to 2021 Equity Incentive Plan.

104
Cover Page Interactive Data File (embedded within the Inline XBRL document)



SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 12th day of June, 2024.





ATI PHYSICAL THERAPY, INC.
By:
/s/ Joseph Jordan
Name:
Joseph Jordan
Title:
Chief Financial Officer



EX-10.4 2 exhibit104.htm EX-10.4 Document


Exhibit 10.4

Amendment No. 3 to the
ATI Physical Therapy, Inc.
2021 EQUITY INCENTIVE PLAN
As adopted by resolution of the Board of Directors on April 25, 2024
The ATI Physical Therapy Inc. 2021 Equity Incentive Plan (“Plan”) is hereby amended by replacing Section 4.1 with the following:
4.1 Number of Shares Reserved. Subject to adjustment as provided in Section 4.2 and Section 4.4 hereof, the total number of shares of Common Stock that are available for issuance under the Plan (the “Share Reserve”) shall equal 5,665,785. Within the Share Reserve, the total number of shares of Common Stock available for issuance as Incentive Stock Options shall equal 5,665,785. In addition, the Share Reserve and the shares of Common Stock available for issuance shall be increased by the number of shares of Common Stock, if any, that were or are forfeited by the participant. Each share of Common Stock subject to an Award shall reduce the Share Reserve by one share. Any shares of Common Stock delivered under the Plan shall consist of authorized and unissued shares or treasury shares.
Except as amended above, the terms of the Plan shall be and remain unchanged, and the Plan as amended is hereby ratified and confirmed and shall remain in full force and effect.

EX-101.SCH 3 ati-20240612.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 ati-20240612_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 ati-20240612_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Document Period End Date Document Period End Date Class of Stock [Domain] Class of Stock [Domain] Pre-commencement Tender Offer Pre-commencement Tender Offer Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Central Index Key Entity Central Index Key Entity Address, City or Town Entity Address, City or Town Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Document Information [Line Items] Document Information [Line Items] Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Cover [Abstract] Warrant Warrant [Member] Entity Emerging Growth Company Entity Emerging Growth Company Common Class A Common Class A [Member] Document Type Document Type Amendment Flag Amendment Flag Class of Stock [Axis] Class of Stock [Axis] Document Information [Table] Document Information [Table] Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name EX-101.PRE 6 ati-20240612_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 8 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover
Jun. 12, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Jun. 12, 2024
Entity Registrant Name ATI Physical Therapy, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-39439
Entity Tax Identification Number 85-1408039
Entity Address, Postal Zip Code 60440
Entity Address, State or Province IL
Entity Address, City or Town Bolingbrook
Entity Address, Address Line One 790 Remington Boulevard
Local Phone Number 296-2223
City Area Code 630
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Document Information [Line Items]  
Amendment Flag false
Entity Central Index Key 0001815849
Common Class A  
Document Information [Line Items]  
Title of 12(b) Security Class A common stock, par value $0.0001
Trading Symbol ATIP
Security Exchange Name NYSE
Warrant  
Document Information [Line Items]  
Title of 12(b) Security Redeemable Warrants, exercisable for Class A common stock at an exercise price of $575.00 per share
Trading Symbol ATIPW
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

-8?20$3;8T.P6BP^0"X99K>]9!:G%C:^?VZH:TE[VE-S9NMQ=%A?BTX'HE'QY%V)N M:I%FGJ:QJ,';>$<-!)U4Q-Z*0CZFL6&P9:P!Q+MTFF6SU%L,9KD8M;:X1+_)UW,#ECQ ,ZE._<]'<')O$8T.,5RMQD)HDU75Z(\4I!K-L5 M3,[E9C(,]L""Q1]ZUYG\M(?8,V(/'U:-Y&:6J6"%'*7?Z/6M>CR#+@^H%7I" M)\!K*_#,U#88CIV,IDAO8O0]C.=0XIS_4R-5%1:PIJ+U$&3HD<%U!D.LL8DF M"=9#;E9T!N[RZ .;O\P>=0>6N=6RKV'5[+E&''\GN4/4$L#!!0 ( +&!S%@D'INBK0 /@! M : >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'.UD3T.@S ,A:\2Y0 U M4*E#!4Q=6"LN$ 7S(Q(2Q:X*MR^% 9 Z=&&RGBU_[\E.GV@4=VZ@MO,D1FL& MRF3+[.\ I%NTBB[.XS!/:A>LXEF&!KS2O6H0DBBZ0=@S9)[NF:*'3^ 5!+ P04 " "Q@O,^>EZS>CQ&PZ)WUV)0= M47P4 E4'3F(=(GBNM"$Y2?R:MB)*M9-;$/?+Y8-0P1-XJBA[E.O5,[1R;ZEX MZ7D;3?!-FI6.5Z*U .EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1 M=#%-)IXPC,^[V?S!9@K(RDT*$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN# MOI'-X_T,:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 M Q0 ( +&!S%@'04UB@0 +$ 0 " 0 !D;V-0 M&UL4$L! A0#% @ L8',6)FRCYSN *P( !$ M ( !KP &1O8U!R;W!S+V-O&UL4$L! A0#% @ L8', M6)E&PO=V]R:W-H965T&UL4$L! A0#% @ L8', M6)^@&_"Q @ X@P T ( !. T 'AL+W-T>6QE&PO=V]R:V)O;VLN>&UL4$L! A0#% @ L8',6"0> MFZ*M ^ $ !H ( !71( 'AL+U]R96QS+W=O9(9 0 SP, !, M ( !0A, %M#;VYT96YT7U1Y<&5S72YX;6Q02P4& D "0 ^ @ &C!0 end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 3 22 1 false 2 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://atiphysicaltherapy.com/role/Cover Cover Cover 1 false false All Reports Book All Reports ati-20240612.htm ati-20240612.xsd ati-20240612_def.xml ati-20240612_lab.xml ati-20240612_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ati-20240612.htm": { "nsprefix": "ati", "nsuri": "http://atiphysicaltherapy.com/20240612", "dts": { "inline": { "local": [ "ati-20240612.htm" ] }, "schema": { "local": [ "ati-20240612.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "ati-20240612_def.xml" ] }, "labelLink": { "local": [ "ati-20240612_lab.xml" ] }, "presentationLink": { "local": [ "ati-20240612_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 2, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 29, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://atiphysicaltherapy.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ati-20240612.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "ati-20240612.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "us-gaap_CommonClassAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonClassAMember", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Common Class A", "label": "Common Class A [Member]" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Line Items]", "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Information [Table]", "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantMember", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant", "label": "Warrant [Member]" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://atiphysicaltherapy.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 16 0001815849-24-000044-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001815849-24-000044-xbrl.zip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end XML 18 ati-20240612_htm.xml IDEA: XBRL DOCUMENT 0001815849 2024-06-12 2024-06-12 0001815849 us-gaap:CommonClassAMember 2024-06-12 2024-06-12 0001815849 us-gaap:WarrantMember 2024-06-12 2024-06-12 false 0001815849 8-K 2024-06-12 ATI Physical Therapy, Inc. DE 001-39439 85-1408039 790 Remington Boulevard Bolingbrook IL 60440 630 296-2223 false false false false Class A common stock, par value $0.0001 ATIP NYSE Redeemable Warrants, exercisable for Class A common stock at an exercise price of $575.00 per share ATIPW false